ISOPROTERENOL HYDROCHLORIDE and DRUG INEFFECTIVE FOR UNAPPROVED INDICATION

Overview

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION is the #13 most commonly reported adverse reaction for ISOPROTERENOL HYDROCHLORIDE, manufactured by Cipla USA Inc.. There are 17 FDA adverse event reports linking ISOPROTERENOL HYDROCHLORIDE to DRUG INEFFECTIVE FOR UNAPPROVED INDICATION. This represents approximately 1.9% of all 894 adverse event reports for this drug.

Patients taking ISOPROTERENOL HYDROCHLORIDE who experience drug ineffective for unapproved indication should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION is a less commonly reported adverse event for ISOPROTERENOL HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of ISOPROTERENOL HYDROCHLORIDE

In addition to drug ineffective for unapproved indication, the following adverse reactions have been reported for ISOPROTERENOL HYDROCHLORIDE:

• DRUG INEFFECTIVE — 113 reports
• TORSADE DE POINTES — 39 reports
• OFF LABEL USE — 38 reports
• VENTRICULAR TACHYCARDIA — 27 reports
• ELECTROCARDIOGRAM QT PROLONGED — 23 reports
• CARDIOGENIC SHOCK — 21 reports
• TOXIC EPIDERMAL NECROLYSIS — 20 reports
• VENTRICULAR FIBRILLATION — 20 reports
• CARDIAC ARREST — 19 reports
• DRUG INTERACTION — 19 reports

Other Drugs Associated with DRUG INEFFECTIVE FOR UNAPPROVED INDICATION

The following drugs have also been linked to drug ineffective for unapproved indication in FDA adverse event reports:

Does ISOPROTERENOL HYDROCHLORIDE cause DRUG INEFFECTIVE FOR UNAPPROVED INDICATION?

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION has been reported as an adverse event in 17 FDA reports for ISOPROTERENOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG INEFFECTIVE FOR UNAPPROVED INDICATION with ISOPROTERENOL HYDROCHLORIDE?

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION accounts for approximately 1.9% of all adverse event reports for ISOPROTERENOL HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience DRUG INEFFECTIVE FOR UNAPPROVED INDICATION while taking ISOPROTERENOL HYDROCHLORIDE?

If you experience drug ineffective for unapproved indication while taking ISOPROTERENOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages